SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-004662
Filing Date
2017-05-02
Accepted
2017-05-02 17:20:16
Documents
5
Period of Report
2017-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29879
2 ex10-1.htm EX-10.1 107172
3 ex99-1.htm EX-99.1 29945
4 ex99-1_01.jpg GRAPHIC 13371
5 ex99-1_02.jpg GRAPHIC 12083
  Complete submission text file 0001493152-17-004662.txt   203637
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 17806185
SIC: 2834 Pharmaceutical Preparations